# Unusual Machines, Inc.: overview

UMAC · NYSE · CIK 1956955 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/umac.md) · [Financials](/companies/umac/financials.md) · [Filings](/companies/umac/filings.md) · [Insiders](/companies/umac/insiders.md)

Latest reported revenue: [$16.7m](/filings/0001683168-26-006016.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001683168-26-006016).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.5](/filings/0001683168-25-008026.md) | [2.0 d](/filings/0001683168-26-001730.md) | [2.0](/filings/0001683168-26-003923.md) | [2.1](/filings/0001683168-26-006016.md) | [2.1](/filings/0001683168-25-008026.md) | [4.9 d](/filings/0001683168-26-001730.md) | [8.1](/filings/0001683168-26-003923.md) | [16.7](/filings/0001683168-26-006016.md) |
| Gross margin | % | [26.1%](/filings/0001683168-25-008026.md) | [27.7% d](/filings/0001683168-26-001730.md) | [24.3%](/filings/0001683168-26-003923.md) | [37.4%](/filings/0001683168-26-006016.md) | [39.4%](/filings/0001683168-25-008026.md) | [36.2% d](/filings/0001683168-26-001730.md) | [32.8%](/filings/0001683168-26-003923.md) | [34.7%](/filings/0001683168-26-006016.md) |
| Operating margin | % | [(95.4%)](/filings/0001683168-25-008026.md) | [(642.3%) d](/filings/0001683168-26-001730.md) | [(160.0%)](/filings/0001683168-26-003923.md) | [(338.5%)](/filings/0001683168-26-006016.md) | [(232.4%)](/filings/0001683168-25-008026.md) | [(198.7%) d](/filings/0001683168-26-001730.md) | [(89.7%)](/filings/0001683168-26-003923.md) | [(46.8%)](/filings/0001683168-26-006016.md) |
| Net margin | % | [(140.0%)](/filings/0001683168-25-008026.md) | [(1353.2%) d](/filings/0001683168-26-001730.md) | [(159.9%)](/filings/0001683168-26-006016.md) | [(327.9%)](/filings/0001683168-26-006016.md) | [75.1%](/filings/0001683168-25-008026.md) | [(215.7%) d](/filings/0001683168-26-001730.md) | [127.0%](/filings/0001683168-26-006016.md) | [(46.5%)](/filings/0001683168-26-006016.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001683168-25-008026.md) | not reported | [(0.21)](/filings/0001683168-26-003923.md) | [(0.32)](/filings/0001683168-26-006016.md) | [0.05](/filings/0001683168-25-008026.md) | not reported | [0.21](/filings/0001683168-26-003923.md) | [(0.16)](/filings/0001683168-26-006016.md) |
| Free cash flow | $m | [(0.5) d](/filings/0001683168-25-008026.md) | [(1.3) d](/filings/0001683168-26-001730.md) | [(1.2)](/filings/0001683168-26-003923.md) | [(2.9) d](/filings/0001683168-26-006016.md) | [(8.8) d](/filings/0001683168-25-008026.md) | [(10.3) d](/filings/0001683168-26-001730.md) | [(18.1)](/filings/0001683168-26-003923.md) | [(21.7) d](/filings/0001683168-26-006016.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001683168-24-005426.md) | [0.0](/filings/0001683168-25-001929.md) | [5.6](/filings/0001683168-26-001730.md) | [11.2](/filings/0001683168-26-001730.md) |
| Gross margin | % | not reported | not reported | [27.8%](/filings/0001683168-26-001730.md) | [34.9%](/filings/0001683168-26-001730.md) |
| Operating margin | % | not reported | not reported | [(305.3%)](/filings/0001683168-26-001730.md) | [(224.6%)](/filings/0001683168-26-001730.md) |
| Net margin | % | not reported | not reported | [(574.6%)](/filings/0001683168-26-001730.md) | [(171.4%)](/filings/0001683168-26-001730.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001683168-24-005426.md) | [(0.72)](/filings/0001683168-25-001929.md) | [(3.84)](/filings/0001683168-26-001730.md) | [(0.74)](/filings/0001683168-26-001730.md) |
| Free cash flow | $m | [(1.2)](/filings/0001683168-24-005426.md) | [(1.8)](/filings/0001683168-25-001929.md) | [(4.0)](/filings/0001683168-26-001730.md) | [(23.2)](/filings/0001683168-26-001730.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/umac/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $81.4m | 3,648,657 |  | Added +2,218,268 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $42.5m | 1,907,459 |  | Added +125,889 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $36.1m | 1,618,266 |  | Added +632,620 |
| [Halter Ferguson Financial Inc.](/funds/1842665.md) | 2026-06-30 | $34.2m | 1,532,348 |  | New +1,532,348 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $33.4m | 1,496,374 |  | Added +1,044,852 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $31.4m | 1,405,902 |  | Reduced −615,516 |
| [Schonfeld Strategic Advisors LLC](/funds/1665241.md) | 2026-06-30 | $29.0m | 1,299,797 |  | Added +1,272,471 |
| [FRONTIER CAPITAL MANAGEMENT CO LLC](/funds/351173.md) | 2026-06-30 | $26.1m | 1,168,543 |  | New +1,168,543 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $25.7m | 1,153,800 | Call | Added +260,500 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $24.9m | 1,116,936 |  | Added +747,073 |

## Recent filings

[All 337 filings](/companies/umac/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 20:14 ET | [8-K](/filings/0001683168-26-008046.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-008046 |
| 2026-10-22 | 12:30 ET | [8-K](/filings/0001683168-26-008013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-008013 |
| 2026-10-07 | 20:05 ET | [8-K](/filings/0001683168-26-007699.md) | 5.07 Shareholder vote results | 0001683168-26-007699 |
| 2026-08-24 | 12:00 ET | [DEF 14A](/filings/0001683168-26-006678.md) | Proxy statement, period 2026-10-05 | 0001683168-26-006678 |
| 2026-08-12 | 20:20 ET | [8-K](/filings/0001683168-26-006280.md) | 4.01 Change of auditor; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-26-006280 |
| 2026-08-11 | 11:59 ET | [8-K](/filings/0001683168-26-006179.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-006179 |
| 2026-08-06 | 11:00 ET | [10-Q](/filings/0001683168-26-006016.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006016 |
| 2026-08-06 | 11:00 ET | [8-K](/filings/0001683168-26-006015.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-006015 |
| 2026-07-28 | 20:01 ET | [8-K](/filings/0001683168-26-005806.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-005806 |
| 2026-06-25 | 12:40 ET | [8-K](/filings/0001683168-26-005100.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-005100 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001683168-26-001730.md), filed Mar 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/fef45123-5e2f-49bb-ab22-4eef69bbf9fa)

## About the filer

- CIK: 1956955
- Tickers: UMAC
- Exchange: NYSE
- SIC code: 3663 Radio & Tv Broadcasting & Communications Equipment
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.